Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
ChiroSolve, Inc. Launches New Method Development Kits
ChiroSolve announces the introduction of two new product packages, EnantioPrep and ScalePrep. - February 06, 2011 - ChiroSolve, Inc.
Advanced Quality & Regulatory Symposium: FDA Speaker & Leading Industry Experts Discuss Compliance Issues in the Drug, Device and Biologics Industry
The 2011 Advanced Quality and Regulatory Symposium for the Biotech and Medical Devices Industry Conference will address the latest regulatory requirements for the development of clinical trials, regulatory submission, and quality systems regulatory requirements for devices, drugs and biologics products. - January 25, 2011 - Monarch Quality Systems Solutions, LLC.
Synpromics Appoints Andrei Lyne as CFO
Synpromics Ltd. is pleased to announce that Andrei Lyne has joined the company as Chief Financial Officer. The new appointment demonstrates Synpromics’s commitment to build a world-class management team to fully exploit the exciting potential of its innovative technology. - January 19, 2011 - Synpromics Ltd
Blue and Red Density Marker Beads Now Available from Cospheric LLC
Cospheric LLC, a microsphere manufacturing and distributing company, recently launched a line of density marker beads in particle size ranges from 10 micron to 600 micron in diameter. Two microsphere product lines having densities of 1.065 g/cc and 1.075 g/cc are currently in stock and ready for... - January 15, 2011 - Cospheric LLC
ALPCO Appoints Cosmo Bio Co., Ltd. as Their New Distribution Channel in Japan
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - January 10, 2011 - ALPCO
The Periogen Company Announces New Tartar-Dissolving Oral Rinse
Periogen Oral Rinse Expected to Revolutionize Oral Home Care The Periogen Company today announced the availability of their premier product Periogen, a home-use oral rinse that dissolves oral tartar with daily application. Periogen is a powdered concentrate which is 25% pure baking soda. It is... - January 08, 2011 - The Periogen Company
A BetterBio Future - BetterBio to Launch February 11th, 2011
BetterBio, Inc. is launching a web platform for discussions on biological technology and its related laws and policies. The site aims to build bridges between industry, academy and community to help citizens become engaged participants in biotechnology policy-making. Everyone has a voice in this... - January 05, 2011 - BetterBio
Affinity Life Sciences Announces Expansion of Their cGMP Manufacturing Facility to Provide Additional Capacity for Biomarker Assay Development and Lyophilization Services
Affinity Life Sciences, Inc. is a New England based contract manufacturing and research organization committed to providing scientific and quality expertise to meet the unique production demands of the biotechnology and pharmaceutical industries worldwide. Affinity's introduction of this space allows for even greater capacity and efficiency for projects ranging from R&D to cGMP compliant production. - December 31, 2010 - Affinity Life Sciences
Eden Spine Vertebral Body Replacement Receives CE Mark Approval
Eden Spine (www.EdenSpine.com), a Florida based Medical Devices organization announced today that the GIZA™was granted CE Mark approval. “The GIZA™ is a new generation VBR, specifically designed to save valuable O.R. time and decrease the risk of subsidence,” says Mourad... - December 17, 2010 - Eden Spine, LLC
Don't Add Extra Variables; Verify with Bio-Synthesis Cell Line Identification
Cell line contamination has plagued the scientific community for decades. Cells used in basic and applied research can become altered in culture, either by contamination from other cell lines or by spontaneous genetic changes. Bio-Synthesis has announced their new service in providing cell line identification and authentication. - December 15, 2010 - Bio-Synthesis Inc.
Strong Growth of HyTest Continues – Revenue Almost 10 Million Euros
In the year 2010 HyTest revenue increased strongly during which the global economic environment continued to create challenges for many other companies. - December 10, 2010 - HyTest Ltd
New THAP11 Antibody from Novus Biologicals
Novus Biologicals just announced a new THAP11 antibody (catalog # NBP1-49463). THAP11 antibodies, also known as Thanatos-associated protein 11 antibodies, are useful for cancer studies and stem cell research. THAP-11 is a regulator of embryonic stem cells and is in the same field as Oct4, Sox2 and Nanog. - December 09, 2010 - Novus Biologicals
Bioo Scientific Awarded Funding from NSF for the Biomolecular Detection of miRNA
Bioo Scientific was recently awarded a grant from the National Science Foundation to support its research for the biomolecular detection of microRNA. - December 08, 2010 - Bioo Scientific
Interest in Sclerostin as a Regulator of Bone Formation Remains High
Sclerostin, a protein produced primarily in osteocytes, inhibits osteoblast activity via antagonism of the wnt signaling pathway and, as such, has garnered a great deal of attention as a potential therapeutic target for increasing bone formation. The annual publication rate for peer-reviewed... - December 07, 2010 - ALPCO
New Report Predicts Growth for Drug Delivery Technologies
This research report categorizes the global market top 10 drug delivery technologies on the basis of their growth, therapeutic areas, patents registered, and industry focus. - December 03, 2010 - MarketResearch.com
Monoclonal Antibodies Market Grew 13% in 08-09
The report provides extensive information and rational analysis of the global monoclonal antibodies market. - December 03, 2010 - MarketResearch.com
SpinalVu, Inc. Announces New Products
SpinalVu, Inc., a wholly owned subsidiary of Global-Med Technologies Group, Inc., announced that it has begun production of two (2) product systems for treatment of spinal disorders and has contracted with SMI of Ocala, Florida to produce its X-Wave™ Cervical Interbody System and X-Wave™ Lumbar Interbody System. - November 29, 2010 - Global-Med Technologies Group Inc (GTG)
Dilyx Launches New Kit for Improved Protein Solubility
Dilyx Biotechnologies, LLC announces the launch of the OptiSol Protein Solubility Screening Kit, allowing research scientists to aggregation-proof their protein samples. The resulting data saves effort and money because it informs life science researchers on how to best treat specific samples for storage or analysis. Find more information at www.dilyx.com - November 19, 2010 - Dilyx Biotechnologies
Biotechnology Pharmaceutical Market in US 2009-2013
Marketsensus released today a new market research report Biotechnology Pharmaceutical Market in US 2009-2013 http://www.marketsensus.com/biotechnology-pharmaceutical-market-20092013-p-96079.html - November 16, 2010 - Marketsensus
Global-Med Technologies Group (GTG) Announces Grand Opening
Global-Med Technologies Group (GTG) invites interested members of the public to visit GTG’s new corporate headquarters on St. Armands Circle in Sarasota, Florida - November 15, 2010 - Global-Med Technologies Group Inc (GTG)
Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials
Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening,... - November 11, 2010 - GenScript USA Inc.
NanoCor Therapeutics, Inc. is Awarded a Grant Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
NanoCor Therapeutics, Inc. (NanoCor) today announced the Company was awarded a grant under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP). The grant is being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care... - November 08, 2010 - NanoCor Therapeutics Inc.
Skyentia Technologies Receives QTDP Grant
Skyentia Technologies LLC has been awarded over $260,000 in qualified investment grants for biotechnology research and development through the Qualified Therapeutic Discovery Program. - November 05, 2010 - Skyentia Technologies
Artezio Participates in BioTech Symposium 2010
Artezio NA General Manager Mr. Sina Adibi participates in the 10th annual BioTech Symposium in Philadelphia, PA on October 27-28. - November 04, 2010 - Artezio
RayBiotech Launches Th17 Antibody Arrays for Immune Research
RayBiotech, Inc., the Protein Array Pioneer Company, today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells. Th17 cells have been linked to the immune response to fungal and certain bacterial infections, as well being associated with several autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and multiple sclerosis. - November 03, 2010 - RayBiotech, Inc
Biotechnology Pharmaceutical Market to Grow 7.7% Annually Through 2013
Biotechnology Pharmaceutical refers to drugs, medicines or vaccines developed through biotechnology such as recombinant DNA technology, combinatorial chemistry, gene therapy, and monoclonal antibodies. - October 29, 2010 - MarketResearch.com
aMarketForce Successfully Completes Phase I of a Market Research Project
aMarketForce, a B2B marketing services and market research company successfully completes Phase I of a Market Research Project - October 27, 2010 - aMarketForce
Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences
Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen. - October 27, 2010 - Biotage
Stemedica International Announces Joint Venture with AnC Bio Group to Manufacture Allogeneic Adult Stem Cells
Stemedica International, S.A., a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products. The new venture, StemedicaAnC, will manufacture allogeneic adult stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. - October 24, 2010 - Stemedica Cell Techechnologies
OctoChem Inc. Announces a New Distribution Model for the Life Science Manufacturer
OctoChem Inc. has announced a new services solution that gives the Life Sciences manufacturer the alternative distribution channel it needs with the complete control and visibility it deserves. - October 23, 2010 - OctoChem, Inc.
curasan AG: Bioactive Bone Regeneration Material Approved for Sale in Europe
curasan AG has received European approval for its new granular bone regeneration material Ceracell® - October 23, 2010 - curasan AG
Voicebrook to Exhibit at 2010 Pathology Visions Conference
Company to discuss challenges, opportunities for VoiceOver® speech recognition, system integration capabilities in Digital Pathology workflow. - October 22, 2010 - Voicebrook, Inc.
BioChain Launches microRNA Signature Validation Kits and Services
The recently released BioChain cancer microRNA signature validation services aim to elucidate the complex microRNA profiling and provide valuable insight to biomarkers implicated in NSCLC diagnosis and therapy. - October 16, 2010 - BioChain Institute, Inc
IonSense Expands Product Line with ASAP Open-Air Ionization Source
IonSense to sell Atmospheric Solids Analysis Probe (ASAP) as Entry Level Source for Open-Air Mass Spectrometry - October 08, 2010 - IonSense, Inc.
AIR™ DNA Sample Prep Kits Now Available for Illumina-Compatible Sequencing Libraries
Bioo Scientific launched the AIR™ Genomic and AIR™ Paired-End DNA Sequencing Kits which offer flexible, cost-effective sample preparation for use with the llumina GAII and HiSeq 2000 sequencers. - October 06, 2010 - Bioo Scientific
RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform
RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010 - RayBiotech, Inc
Health Resources™ Announces the Upcoming Release of New Immune-Balancing Formula
According to updated research presented by the National Institute of Allergy and Infectious Diseases, more than 200,000 people are hospitalized from the flu and its complications each year. This amounts to missed work days, canceled plans and less-than-optimal health levels. What’s more, the... - October 02, 2010 - Health Resources
Algae 2020 Study Identifies High Value Markets and Producers of Biofuels, Biochemicals, Bioplastics, Biojet, Animal Feed, Omega 3s and Heart Healthy Oils
The Algae 2020, vol 2 global tour and study addresses and answers the key question "when will algae for biofuels be commercially viable, and which companies and projects are presently best positioned to meet this challenge? How will biochemicals, biopolymers and high value product markets be achieved? - September 30, 2010 - Emerging Markets Online
ChemDAQ Inc. Awarded Three-year Agreement with MAGNET
Steri-Trac(R) Monitoring System to be available to MAGNET Member Organizations - September 25, 2010 - ChemDAQ, Incorporated
2010 BioWest Conference & Expo to Showcase 40+ New Technologies, Products and Services
More than 40 exhibitors will be showcasing new technology, products and services for 500+ attendees at the 2010 BioWest Conference & Expo, September 29 and 30, at the Grand Hyatt Denver, 1750 Welton. BioWest, in its eighth year, is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. - September 23, 2010 - Colorado BioScience Association
Bioo Scientific Launched Color Endpoint Assays for In Vivo AST and LDH Analysis
Today Bioo Scientific launched the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays for in vivo toxicity analysis. - September 16, 2010 - Bioo Scientific
AnaSpec Introduces Histone GO® Peptides
AnaSpec, the world’s largest provider of on-demand GO® peptides has introduced a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone H3 GO ® Peptides include sequences that are acetylated, mono-, di- or tri-methylated,... - September 16, 2010 - AnaSpec, EGT Group
Four Finalists Selected for BioWest 2010 Venture Showcase Competition, Presenting Life-Changing Technologies
Cutting-edge development of a universal influenza vaccine, creation of an innovative hybridCpeptide manufacturing process, groundbreaking wastewater treatment through a new algae production system, and a revolutionary nontoxic surface treatment to control the growth of bacteria in hospitals, comprise the four finalists in this year’s BioWest Venture Showcase competition. - September 13, 2010 - Colorado BioScience Association
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors
F2G Limited, the UK based antifungal drug discovery and development company, today announced the appointment of Dr Michael R. Hodges to the Company’s Board of Directors. Michael R Hodges, M.D., BSc., MRCP (UK) has 20 years of biopharmaceutical development experience and has worked in both... - September 13, 2010 - F2G Ltd
Bioinformatics Market to Grow 26% Annually Through 2013
This study focuses on the bioinformatics market, including bioinformatics genomics, bioinformatics proteomics, bioinformatics pharmacogenomics, and bioinformatics drug discovery and cheminformatics. - September 10, 2010 - MarketResearch.com
Lymphedema Depot Provides Guides to Solaris Products
Lymphedema Depot has assembled a series of Product Guides to help therapists and patients decide what therapeutic products best fit their condition. The Product Guides are single-page documents that suggest particular Solaris products that can be used for certain conditions. The Solaris products... - September 09, 2010 - Lymphedema Depot Ltd.
Biotage Introduces Resolux™ Peptides Purification HPLC Columns to Address Increasing Global Demand
Biotage has launched a new range of HPLC columns optimized for peptide purification. The Resolux line was introduced during the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and will be premiered at the 31st European Peptide Symposium on September 5th in Copenhagen, Denmark. - September 04, 2010 - Biotage
Media, Sera, & Reagent Market to Reach 3.8 Billion by 2015
This study focuses on the cell culture media, sera, and reagent markets. - August 27, 2010 - MarketResearch.com
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit
AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group